Cytodyn Inc (CYDY)

$0.29 0.00 (N/A)
Market Cap 343.05M
Revenue (ttm) 0.00
Net Income (ttm) 3.75M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 705,657
Avg Vol 1,877,754
Day's Range N/A - N/A
Shares Out 1.27B
Stochastic %K 69%
Beta 1.12
Analysts Strong Buy
Price Target $4.00

Company Profile

CytoDyn Inc., a clinical-stage biotechnology company, develops treatments for multiple therapeutic indications. It is involved in the clinical development of leronlimab, a novel humanized monoclonal antibody targeting the C-C chemokine receptor type 5 receptor in the areas of COVID-19. The company's leronlimab is currently under phase 2 development for the treatment of micro-satellite stable colorectal cancer, and solid tumors in oncology, such as metastatic triple-negative breast cancer. The co...

Industry: Biotechnology
Sector: Healthcare
Phone: 360 980 8524
Fax: 360 799 5954
Address:
1111 Main Street, Suite 660, Vancouver, United States
LogicAlways
LogicAlways Jan. 6 at 11:15 PM
$CYDY New decoration at the White House. Maybe $DIS will have this in the next Mandolorian episode. Nothing about Leronlimab yet.
0 · Reply
ThreePointsPlus1
ThreePointsPlus1 Jan. 6 at 10:10 PM
$CYDY RFK, Jr. decision to not recommend child vaccinations is based on his personal ideology, and is opposed by virtually all American pediatricians. Child abuse by RFK, Jr.
5 · Reply
Cytomight
Cytomight Jan. 6 at 10:06 PM
$CYDY Hearing there is SIGNIFICANT ,mybe overwhelming ,number of EIND requests ‼️😆
5 · Reply
GOCYDY
GOCYDY Jan. 6 at 8:26 PM
$CYDY NOTHING BUT 
0 · Reply
Anti_LLheaters
Anti_LLheaters Jan. 6 at 8:15 PM
$CYDY efficacy is already proved, this time in big numbers. We are just making sure nobody can refuted anymore, especially your boss … mazzytard1
3 · Reply
Fredsavage911
Fredsavage911 Jan. 6 at 8:07 PM
$CYDY Either u think the CRC trial will be successful or you don’t. If u don’t u move along. Hard for some to let go when they have been so butthurt in the past I guess. Pretty pathetic. Go on say ur just “protecting possible investors”. Meanwhile over the past year SP is up 140% ⬇️ that’s a lot of ifs and butts from a real butthurt basher ⬇️
1 · Reply
ThreePointsPlus1
ThreePointsPlus1 Jan. 6 at 8:03 PM
$CYDY To any and all new followers on this CYDY chat board, please understand that there is one persistent CytoDyn critic in here who trolls CYDY incessantly under several different screen names. This person acknowledges having a personal grievance against CytoDyn management, which is why this person trolls CYDY constantly. . . all day. . . all night. . . weekdays. . . weekends. . . for many years now. . . classic obsessive/compulsive behavior of someone in need of therapy. This person posts under screen names mazzystar1, ghostofMS, tstone8989, and others. And those posts receive 'likes' only from the aliases of this one person. Newcomers on this CYDY chat board should regard all posts from any of those screen names as intentional disinformation about CytoDyn and Leronlimab.
2 · Reply
mazzystar1
mazzystar1 Jan. 6 at 8:00 PM
$CYDY pumpers can put all the quotes on this board about the great potential of LL that they want to... but it doesn't change the fact that unless CYDY can show EFFICACY for ANY indication, then LL is completely worthless... and in 25 clinical trials over 22 years, CYDY has NOT demonstrated EFFICACY... CYDY management can expound on how LL is "paradigm shifting" or other colorful quotes, but those soundbites will NOT get a drug approval... clinical trial data gets a drug approved... and CYDY has been dreadful in designing clinical trials as proven by their ONLY active trial... and if they don't get approval to change the CRC clinical trial running right now to add an ICI, the trial WILL be a complete failure and they are going to have to discontinue the trial... that would be a MAJOR setback...
1 · Reply
stocktwits_for_cydy_gm
stocktwits_for_cydy_gm Jan. 6 at 7:59 PM
$CYDY https://www.tagesschau.de/wissen/forschung/klinische-studien-2026-100.html Intereesting part: "New immunotherapy for breast cancer Breast cancer is the most common type of cancer in women and can already be treated effectively in most cases. However, if the cancer has spread, the prognosis is often poor. For these cases, a new cell-based immunotherapy for breast cancer patients is currently being tested, in which antibodies specifically activate the immune system of those affected. Among other things, the immune system is trained with proteins from breast cancer cells. At the same time, cells of the immune system are activated. Forty treatment centers worldwide are participating in the clinical trial. The research team is also looking for biomarkers to predict as accurately as possible before therapy which patients would benefit most from the therapy." Could this be ... ?
0 · Reply
WagonTrain
WagonTrain Jan. 6 at 7:58 PM
$CYDY Looking for a new time to altitude record.
0 · Reply
Latest News on CYDY
No data available.
LogicAlways
LogicAlways Jan. 6 at 11:15 PM
$CYDY New decoration at the White House. Maybe $DIS will have this in the next Mandolorian episode. Nothing about Leronlimab yet.
0 · Reply
ThreePointsPlus1
ThreePointsPlus1 Jan. 6 at 10:10 PM
$CYDY RFK, Jr. decision to not recommend child vaccinations is based on his personal ideology, and is opposed by virtually all American pediatricians. Child abuse by RFK, Jr.
5 · Reply
Cytomight
Cytomight Jan. 6 at 10:06 PM
$CYDY Hearing there is SIGNIFICANT ,mybe overwhelming ,number of EIND requests ‼️😆
5 · Reply
GOCYDY
GOCYDY Jan. 6 at 8:26 PM
$CYDY NOTHING BUT 
0 · Reply
Anti_LLheaters
Anti_LLheaters Jan. 6 at 8:15 PM
$CYDY efficacy is already proved, this time in big numbers. We are just making sure nobody can refuted anymore, especially your boss … mazzytard1
3 · Reply
Fredsavage911
Fredsavage911 Jan. 6 at 8:07 PM
$CYDY Either u think the CRC trial will be successful or you don’t. If u don’t u move along. Hard for some to let go when they have been so butthurt in the past I guess. Pretty pathetic. Go on say ur just “protecting possible investors”. Meanwhile over the past year SP is up 140% ⬇️ that’s a lot of ifs and butts from a real butthurt basher ⬇️
1 · Reply
ThreePointsPlus1
ThreePointsPlus1 Jan. 6 at 8:03 PM
$CYDY To any and all new followers on this CYDY chat board, please understand that there is one persistent CytoDyn critic in here who trolls CYDY incessantly under several different screen names. This person acknowledges having a personal grievance against CytoDyn management, which is why this person trolls CYDY constantly. . . all day. . . all night. . . weekdays. . . weekends. . . for many years now. . . classic obsessive/compulsive behavior of someone in need of therapy. This person posts under screen names mazzystar1, ghostofMS, tstone8989, and others. And those posts receive 'likes' only from the aliases of this one person. Newcomers on this CYDY chat board should regard all posts from any of those screen names as intentional disinformation about CytoDyn and Leronlimab.
2 · Reply
mazzystar1
mazzystar1 Jan. 6 at 8:00 PM
$CYDY pumpers can put all the quotes on this board about the great potential of LL that they want to... but it doesn't change the fact that unless CYDY can show EFFICACY for ANY indication, then LL is completely worthless... and in 25 clinical trials over 22 years, CYDY has NOT demonstrated EFFICACY... CYDY management can expound on how LL is "paradigm shifting" or other colorful quotes, but those soundbites will NOT get a drug approval... clinical trial data gets a drug approved... and CYDY has been dreadful in designing clinical trials as proven by their ONLY active trial... and if they don't get approval to change the CRC clinical trial running right now to add an ICI, the trial WILL be a complete failure and they are going to have to discontinue the trial... that would be a MAJOR setback...
1 · Reply
stocktwits_for_cydy_gm
stocktwits_for_cydy_gm Jan. 6 at 7:59 PM
$CYDY https://www.tagesschau.de/wissen/forschung/klinische-studien-2026-100.html Intereesting part: "New immunotherapy for breast cancer Breast cancer is the most common type of cancer in women and can already be treated effectively in most cases. However, if the cancer has spread, the prognosis is often poor. For these cases, a new cell-based immunotherapy for breast cancer patients is currently being tested, in which antibodies specifically activate the immune system of those affected. Among other things, the immune system is trained with proteins from breast cancer cells. At the same time, cells of the immune system are activated. Forty treatment centers worldwide are participating in the clinical trial. The research team is also looking for biomarkers to predict as accurately as possible before therapy which patients would benefit most from the therapy." Could this be ... ?
0 · Reply
WagonTrain
WagonTrain Jan. 6 at 7:58 PM
$CYDY Looking for a new time to altitude record.
0 · Reply
jvnpppl
jvnpppl Jan. 6 at 7:54 PM
$CYDY longtime bullish here…
0 · Reply
Twinter11
Twinter11 Jan. 6 at 7:40 PM
$CYDY "data showing that chemokines are bad for solid tumors, increasing proliferation, motility, invasion, and metastasis. So you can block those phenotypes as one mechanism of action of leronlimab, which is impressive. And then perhaps even more exciting is demonstrated in a translational fashion in humans that the preclinical data showing upregulation of PD-L1 by leronlimab in the lab happens in people".
2 · Reply
Lousir
Lousir Jan. 6 at 7:35 PM
$CYDY
0 · Reply
Twinter11
Twinter11 Jan. 6 at 7:35 PM
$CYDY "And so turning cold to hot has been a long sought-after phenotype goal in immunotherapy of breast cancer."
1 · Reply
psaunders
psaunders Jan. 6 at 7:34 PM
$CYDY Very bullish. Sentiment meter is broke.
1 · Reply
BullishTexas
BullishTexas Jan. 6 at 7:28 PM
$CYDY 29, 29, 29, and 29 again. #manipulators suck but I'm still
0 · Reply
Cytomight
Cytomight Jan. 6 at 7:27 PM
$CYDY Unbelievably
0 · Reply
leoncashmoney
leoncashmoney Jan. 6 at 7:24 PM
$CYDY screw these shorts, let’s turn this sentiment around…any of you longs bullish?!
4 · Reply
Twinter11
Twinter11 Jan. 6 at 7:21 PM
$CYDY "So I think it's really exciting. It's just great. This is the kind of thing that makes the meeting as opposed to the plenary industry-sponsored large phase III trials, some of which are practice-changing and important, but some of them that are not. And so I'd rather see this on the podium any day than a lot of the things that we normally see at"...
0 · Reply
Twinter11
Twinter11 Jan. 6 at 7:16 PM
$CYDY "I'm fascinated by this drug leronlimab and its mechanism with this chemokine target. And I'm really excited to see what the phase II study shows."
1 · Reply
Fredsavage911
Fredsavage911 Jan. 6 at 7:14 PM
$CYDY I mean there’s nothing there that says the 700 mg dose was denied. Pretty odd someone would try to convince other people it was denied. Almost like they are trying to manipulate the stock price down by spreading doubt. I mean provide evidence it was denied if you claim it is so.
1 · Reply
OB1_
OB1_ Jan. 6 at 7:06 PM
$CYDY $NWBO another normal day of trading. Shorts scrambling
2 · Reply